KVK Tech

KVK Tech is a private, commercial-stage generic pharmaceutical company headquartered in Newtown, Pennsylvania, USA. It has established itself as a manufacturer of high-quality, FDA-approved generic medicines, with a notable branded product, Lomaira (phentermine), and a strong commitment to U.S.-based manufacturing and quality. The company's strategy focuses on cost-effective alternatives for patients, though it navigates a competitive generic landscape and has faced recent legal scrutiny, as indicated by a deferred prosecution agreement in its public filings.

Integrated U.S.-based pharmaceutical manufacturing, packaging, and distribution infrastructure with capabilities in formulation development, chemistry, manufacturing & controls (CMC), and ANDA submission for generic drugs.

KVK competes in the crowded generic pharmaceutical market against large global players like Teva, Sandoz, and Viatris, as well as numerous other U.S. generic manufacturers. Its domestic production is a key differentiator, but it must compete on price, quality, and portfolio breadth against well-established rivals.